Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
29.42
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
3 No-Brainer Stocks to Buy With $100 Right Now
July 10, 2024
You don't need a mountain of cash to grow your wealth on Wall Street.
Via
The Motley Fool
Pfizer Launches Process To Identify Chief Scientific Officer Successor
July 09, 2024
Pfizer announced its starting the process to find a new chief scientific officer and president of Pfizer Research and Development.
Via
Benzinga
The 3 Most Undervalued Large-Cap Stocks to Buy in July 2024
July 09, 2024
Looking for standout picks this summer? These three undervalued large-cap stocks to buy now are compelling opportunities.
Via
InvestorPlace
Pfizer Options Trading: A Deep Dive into Market Sentiment
July 09, 2024
Via
Benzinga
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024
July 09, 2024
Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge.
Via
InvestorPlace
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
July 08, 2024
Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health.
Via
Talk Markets
What the Options Market Tells Us About Pfizer
July 03, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Pfizer Through 9 Analysts
July 01, 2024
Via
Benzinga
Pfizer's RSV Vaccine Abrysvo Clears Concerns Over Preterm Birth Risk, Safety For Pregnant Women, New Study Shows
July 08, 2024
Pfizer's RSV vaccine, Abrysvo, for pregnant women shows no increased risk of pre-term births, according to a study. Researchers found no significant difference in pre-term birth rates between...
Via
Benzinga
3 Overlooked Giants-in-the-Making for Patient Investors
July 08, 2024
Consider buying into these overlooked growth stocks for long-term profits that will help to boost a portfolio and deliver riches.
Via
InvestorPlace
Want $1,000 in Dividend Income? Here's How Much You Have to Invest in Pfizer Stock
July 08, 2024
Don't ignore this drugmaker simply because it's been unable to come up with a full replacement for Lipitor.
Via
The Motley Fool
Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip?
July 08, 2024
Shares of the world's largest drugmaker offer a dividend yield above 6% at recent prices.
Via
The Motley Fool
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
July 07, 2024
The GLP-1 drug market for obesity treatment is expected to skyrocket to $1 trillion or more, according to Maurits Pot, founder and CEO of Tema ETFs.
Via
Benzinga
Topics
ETFs
3 Bargain Stocks With the Potential for Mind-Boggling Returns
July 07, 2024
Discover three bargain stocks leading in healthcare and pharmaceuticals with fundamentals behind their potential for massive returns.
Via
InvestorPlace
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in July
July 06, 2024
Adding these dividend payers to your portfolio is a nearly certain way to boost your passive income stream.
Via
The Motley Fool
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
July 05, 2024
UK regulators reprimand Novo Nordisk for failing to disclose nearly $10 million in fees and expenses. The PMCPA cites breaches in financial categorization and highlights similar issues with Novartis...
Via
Benzinga
3 Dividend Stocks That Are Screaming Buys in July
July 05, 2024
Income-seeking investors will want to move on these stocks sooner rather than later.
Via
The Motley Fool
Upcoming Stock Spinoffs: Should You Pounce or Pass?
July 04, 2024
Stock spinoffs are a unique opportunity to pick up unloved, unwanted businesses but patience is often needed before buying in.
Via
InvestorPlace
7 Juicy Dividend Stocks That Have Grown for More Than a Decade
July 04, 2024
These long-term dividend growth stocks offer relatively juicy yields above 4% along with overall stability,
Via
InvestorPlace
How To Buy Growth Stocks In An Economy That Isn’t Growing
July 03, 2024
The S&P 500 and Nasdaq both hit record highs today - in a shortened, not-very-exciting trading session.
Via
Talk Markets
Topics
Economy
Stocks
Exposures
Economy
US Equities
3 Undervalued Stocks Poised for a Jaw-Dropping Breakout
July 03, 2024
These three undervalued stocks have immense potential for a jaw-dropping breakout, offering triple-digit upside in the coming years.
Via
InvestorPlace
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
July 03, 2024
GSK and CureVac restructured their collaboration into a new licensing agreement, prioritizing mRNA vaccine development. GSK gains full control of vaccine candidates for influenza and COVID-19, while...
Via
Benzinga
Exposures
COVID-19
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents
July 02, 2024
Pfizer and Moderna continue their legal battle over COVID-19 vaccine patents following a mixed ruling by London's High Court, with potential appeals on the horizon and significant financial stakes...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims
July 02, 2024
A Delaware judge dismissed GSK and other drugmakers' appeal, allowing over 70,000 lawsuits alleging Zantac causes cancer to proceed, with the companies needing Delaware Supreme Court approval to...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
1 Underwhelming Stat That May Have You Thinking Twice About Buying Pfizer's Stock
July 02, 2024
Pfizer's valuation looks attractive, but that doesn't mean the stock is a lock to outperform the broader market.
Via
The Motley Fool
3 Under-the-Radar Biotech Stocks With Blockbuster Potential
July 02, 2024
Are you looking to boost your portfolio with the best under-the-radar biotech stocks? Here are the top three.
Via
InvestorPlace
Time to Pounce: 2 Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought for the Second Half of 2024 (and Beyond)
July 02, 2024
Two high-octane income stocks, which are premier companies sporting 6% yields within their respective industries, are historically cheap and ripe for the picking.
Via
The Motley Fool
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
July 01, 2024
There are more marketplace opportunities than just AI which is why these stocks that are outperforming Nvidia have done so well.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Amazon Web Services Focuses On The Future, Anticipating AI Challenges Years In Advance To Deliver 'True Value' For Customers
July 01, 2024
Amazon is taking an all-encompassing approach to enterprise AI in an effort to better deliver the tools that customers need when they need them.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Dividend Stocks Yielding Over 3% With Multi-Decade Payout Growth Streaks
July 01, 2024
Explore three high-yield dividend stocks that not only offer yields of 3% or more but also boast multiple decades of payout growth.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.